Health Catalyst (HCAT) CEO executes mandated sell-to-cover tax transaction

Rhea-AI Filing Summary

Health Catalyst, Inc. CEO Albert Benjamin reported a mandatory tax-withholding share disposition. On March 10, 2026, he disposed of 70,455 shares of common stock at $1.8481 per share to cover tax obligations tied to vesting restricted stock units.

This “sell to cover” transaction was mandated under the company’s equity incentive plans and is described as not a discretionary trade by Benjamin. After this tax-withholding event, he directly holds 1,457,978 shares of Health Catalyst common stock.

Insider Trade Summary

Net Seller: 70,455 shares

Net Sell 1 txn

Insider Albert Benjamin

Role CEO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	70,455	$1.8481	$130K

Holdings After Transaction: Common Stock — 1,457,978 shares (Direct)

Footnotes (1)

1. F1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/13/2026 - 08:13 AM Learn about SEC filing dates

FAQ

What insider transaction did Health Catalyst (HCAT) report for CEO Albert Benjamin?

Health Catalyst reported CEO Albert Benjamin disposed of shares to cover taxes. He used 70,455 common shares at $1.8481 per share in a mandated “sell to cover” transaction related to vesting restricted stock units.

Was the Health Catalyst (HCAT) CEO’s Form 4 share sale a discretionary trade?

No, the CEO’s share sale was not discretionary. The filing states the 70,455 shares were sold solely to satisfy tax withholding obligations under the company’s equity incentive plans through a required “sell to cover” transaction.

How many Health Catalyst (HCAT) shares does CEO Albert Benjamin hold after this Form 4?

After the reported tax-withholding disposition, CEO Albert Benjamin directly holds 1,457,978 shares of Health Catalyst common stock. This shows he retains a substantial equity position following the mandated “sell to cover” transaction.

What price was used for the CEO’s tax-withholding share sale at Health Catalyst (HCAT)?

The tax-withholding sale used a price of $1.8481 per share. This price applied to 70,455 shares of Health Catalyst common stock sold to cover tax obligations from vesting restricted stock units.

Why did Health Catalyst (HCAT) CEO need to sell shares in this Form 4 filing?

The CEO sold shares to fund tax withholding on vesting restricted stock units. Under the company’s equity incentive plans, tax obligations are satisfied through an automatic “sell to cover” transaction rather than a voluntary open-market trade.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Albert Benjamin

(Last) (First) (Middle)

10897 S. RIVER FRONT PARKWAY

SUITE 300

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/10/2026		F		70,455(1)	D	$1.8481	1,457,978	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	03/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.